Simultaneous Overexpression of miR-126 and miR-34a Induces a Superior Antitumor Efficacy in Pancreatic Adenocarcinoma [Retraction]

Feng S-D, Mao Z, Liu Chunying, Nie Y-S, Sun B, Guo M,Su C. Simultaneous overexpression of miR-126 and miR-34a induces a superior antitumor efficacy in pancreaticadenocarcinoma. Onco Targets Ther. 2017;10:5591–5604.The Editor-in-Chief and Publisher of OncoTargets andTherapy wish to retract the published article. Concerns were raised to the Editor-in-Chief regarding thepossibility of some image manipulation in the publishedarticle. The alleged manipulation relates to Figure 2AAdCEAp-EGFP Panc-1 and AdCEAp-EGFP BxPC3. Itappears the same image had been used in both panels butwith the fluorescence intensity altered.The authors were asked for an explanation but were unableto provide a satisfactory explanation for the duplicatedimages and could not clearly account for the altered fluorescenceintensity. The Editor-in-Chief raised doubts about the validity of theresults and determined that simply replacing the images inquestion not been adequately justified by the authors. The authors wish to apologise for the error. Our decision-making was informed by our policy on publishingethics and integrity and the COPE guidelines onretraction. The retracted article will remain online to maintain thescholarly record, but it will be digitally watermarked oneach page as “Retracted”. This retraction relates to this paper